A 73-year-old patient undergoing treatment for relapsed acute lymphoblastic leukaemia (ALL) was admitted to our unit with severe pneumonia. He had just completed 4 weeks of reinduction chemotherapy using prednisolone, vincristine, daunorubicin and asparaginase and was in morphological remission from ALL. During the course of admission he developed acute complete bilateral visual loss with preserved pupillary responses. His conscious level was not impaired and there was no apparent neurological deficit in the limbs. These features suggested bilateral pathology affecting the occipital and/or posterior parietal cortices and we suspected venous infarction from a sagittal sinus thrombosis. This was confirmed on a contrast computed tomography (CT) scan (left), which showed the characteristic ‘delta sign’ a triangle of non-enhancing thrombus in the sagittal sinus (long arrow). CT (right) also demonstrated peri-ventricular white matter oedema (thin arrows) and atypical posterior parietal lobe infarction bilaterally (thick arrows). These venous infarcts had damaged both optic radiations and were responsible for the cortical blindness. We considered anticoagulation and antithrombin replacement but with established cortical infarcts the likelihood of significant visual recovery was low. We elected for supportive care only, because of his progressive respiratory failure. Venous thrombosis is a recognized complication of asparaginase therapy, having been reported in up to 37% of patients undergoing treatment with asparaginase for ALL. It is attributed to depletion of natural anticoagulants, particularly antithrombin. It tends to affect unusual areas, such as cerebral venous sinuses and upper limb veins. The risk appears to be higher in adults, in patients receiving Escherichia colirather than Erwinia-derived asparaginase and in patients receiving concurrent prednisolone therapy. Other common risk factors, such as immobility, sepsis and central venous catheters, can play a role in increasing this risk. Where venous sinus thrombosis is suspected it is important to perform a venous phase contrast CT where scanning starts at least 60 s post-injection. A thrombus is identified as an intra-sinus filling defect amidst the contrast in the venous sinus blood. A standard post-contrast CT is normally imaged at 20–30 s; this may be too early for contrast to reach cerebral venous sinuses and this life-threatening condition may be overlooked.